Obesity in PraderWilli syndrome: physiopathological mechanisms, nutritional and pharmacological approaches
GLP-1 receptor agonists semaglutide, liraglutide, dulaglutide and the GIP/GLP-1 dual agonist tirzepatide act on appetite, satiety, and gastric emptying
By promoting collagen synthesis, peptides help enhance skin elasticity, reduce fine lines and wrinkles, and improve overall texture
Factors such as: Degree of insulin resistance Presence of other conditions (cardiovascular disease, fatty liver disease, sleep apnoea) Family history of diabetes or obesity Age and menopausal status Previous weight loss attempts and patterns of weight regain Safety considerations and tolerability play an important role
Since PCOS-related infertility is primarily driven by insulin resistance and excess androgens, addressing these root causes through GLP-1 therapy can normalize menstrual cycles and improve egg quality
Administration site: Subcutaneous injection as close to the affected spinal segment as practical
